Concepts (199)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hospitals, Public | 2 | 2019 | 38 | 0.700 |
Why?
|
| Safety-net Providers | 1 | 2019 | 41 | 0.640 |
Why?
|
| Health Services Research | 1 | 2019 | 185 | 0.590 |
Why?
|
| Informed Consent | 2 | 2024 | 338 | 0.550 |
Why?
|
| Acquired Immunodeficiency Syndrome | 5 | 1999 | 233 | 0.500 |
Why?
|
| Tuberculosis, Miliary | 1 | 2015 | 11 | 0.490 |
Why?
|
| Tuberculosis, Pleural | 1 | 2015 | 10 | 0.490 |
Why?
|
| PubMed | 1 | 2015 | 21 | 0.490 |
Why?
|
| Antimalarials | 2 | 2012 | 37 | 0.460 |
Why?
|
| Health Status Indicators | 1 | 2014 | 117 | 0.450 |
Why?
|
| Brain Diseases | 3 | 2006 | 294 | 0.400 |
Why?
|
| Emigration and Immigration | 5 | 2007 | 78 | 0.400 |
Why?
|
| Malaria | 1 | 2012 | 81 | 0.390 |
Why?
|
| Disease Outbreaks | 7 | 1996 | 318 | 0.370 |
Why?
|
| Peripheral Nervous System | 1 | 2010 | 42 | 0.350 |
Why?
|
| Public Health | 2 | 2024 | 253 | 0.340 |
Why?
|
| Neurocysticercosis | 2 | 2006 | 21 | 0.340 |
Why?
|
| HIV-1 | 3 | 2010 | 463 | 0.320 |
Why?
|
| Central Nervous System | 1 | 2010 | 253 | 0.320 |
Why?
|
| HIV Infections | 5 | 2010 | 1858 | 0.310 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2010 | 265 | 0.300 |
Why?
|
| Developing Countries | 1 | 2010 | 270 | 0.300 |
Why?
|
| Uncompensated Care | 1 | 2007 | 10 | 0.290 |
Why?
|
| Antitubercular Agents | 1 | 2010 | 344 | 0.290 |
Why?
|
| Nervous System Diseases | 1 | 2010 | 367 | 0.270 |
Why?
|
| Social Justice | 1 | 2024 | 55 | 0.230 |
Why?
|
| Health Care Costs | 1 | 2007 | 360 | 0.230 |
Why?
|
| Socioeconomic Factors | 2 | 2019 | 853 | 0.220 |
Why?
|
| Tuberculosis | 1 | 2010 | 570 | 0.220 |
Why?
|
| Malaria, Cerebral | 1 | 2003 | 4 | 0.220 |
Why?
|
| Cysticercosis | 2 | 1994 | 16 | 0.220 |
Why?
|
| Malaria, Falciparum | 1 | 2003 | 44 | 0.210 |
Why?
|
| Sarcoma, Kaposi | 2 | 1998 | 120 | 0.210 |
Why?
|
| Personal Autonomy | 1 | 2024 | 200 | 0.210 |
Why?
|
| Humans | 38 | 2024 | 122120 | 0.200 |
Why?
|
| Psychotic Disorders | 1 | 2003 | 139 | 0.200 |
Why?
|
| Relief Work | 1 | 2001 | 31 | 0.190 |
Why?
|
| Housing | 1 | 2001 | 60 | 0.190 |
Why?
|
| Population Surveillance | 4 | 2012 | 381 | 0.180 |
Why?
|
| Texas | 9 | 2012 | 3513 | 0.180 |
Why?
|
| Orbit | 1 | 2001 | 103 | 0.180 |
Why?
|
| Disasters | 1 | 2001 | 99 | 0.170 |
Why?
|
| Craniocerebral Trauma | 1 | 2001 | 140 | 0.170 |
Why?
|
| HIV Seroprevalence | 1 | 1999 | 9 | 0.170 |
Why?
|
| Delivery of Health Care | 3 | 2019 | 604 | 0.170 |
Why?
|
| Private Sector | 1 | 2019 | 24 | 0.170 |
Why?
|
| Utilization Review | 1 | 1999 | 38 | 0.170 |
Why?
|
| Birth Rate | 1 | 2019 | 17 | 0.170 |
Why?
|
| Blood Donors | 1 | 1999 | 62 | 0.170 |
Why?
|
| Kidney Failure, Chronic | 1 | 2007 | 861 | 0.160 |
Why?
|
| Nutritional Status | 1 | 2001 | 295 | 0.160 |
Why?
|
| Cities | 1 | 2019 | 47 | 0.160 |
Why?
|
| Geography | 1 | 2019 | 112 | 0.160 |
Why?
|
| Liver Abscess, Amebic | 1 | 1998 | 3 | 0.160 |
Why?
|
| Community Health Services | 1 | 1999 | 90 | 0.160 |
Why?
|
| Regression Analysis | 2 | 2019 | 749 | 0.150 |
Why?
|
| Infant Mortality | 1 | 2019 | 175 | 0.150 |
Why?
|
| Mortality | 1 | 2019 | 222 | 0.150 |
Why?
|
| Global Health | 2 | 2014 | 555 | 0.150 |
Why?
|
| Data Collection | 1 | 2019 | 383 | 0.140 |
Why?
|
| Quality of Life | 1 | 2007 | 1905 | 0.140 |
Why?
|
| Pandemics | 1 | 2024 | 1101 | 0.140 |
Why?
|
| Internationality | 1 | 1996 | 128 | 0.130 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 1403 | 0.130 |
Why?
|
| Topography, Medical | 1 | 2014 | 6 | 0.120 |
Why?
|
| Health Policy | 1 | 1996 | 207 | 0.120 |
Why?
|
| Adult | 16 | 2012 | 28676 | 0.110 |
Why?
|
| Middle Aged | 13 | 2012 | 25538 | 0.110 |
Why?
|
| Vibrio Infections | 2 | 1983 | 16 | 0.110 |
Why?
|
| Vibrio | 2 | 1983 | 11 | 0.110 |
Why?
|
| Cross-Cultural Comparison | 1 | 2013 | 60 | 0.110 |
Why?
|
| Travel | 2 | 2012 | 117 | 0.110 |
Why?
|
| Terminology as Topic | 1 | 2015 | 226 | 0.110 |
Why?
|
| Europe | 1 | 2014 | 369 | 0.110 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2014 | 47 | 0.110 |
Why?
|
| United States | 4 | 2019 | 10459 | 0.110 |
Why?
|
| Male | 19 | 2012 | 59429 | 0.100 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2014 | 128 | 0.100 |
Why?
|
| Anti-Retroviral Agents | 1 | 2014 | 135 | 0.100 |
Why?
|
| Cluster Analysis | 1 | 2013 | 386 | 0.100 |
Why?
|
| Campylobacter jejuni | 1 | 1992 | 4 | 0.100 |
Why?
|
| Clostridium Infections | 2 | 1988 | 230 | 0.100 |
Why?
|
| Campylobacter Infections | 1 | 1992 | 34 | 0.100 |
Why?
|
| Female | 18 | 2012 | 64764 | 0.100 |
Why?
|
| Central America | 3 | 2005 | 20 | 0.100 |
Why?
|
| Seizures | 2 | 1994 | 868 | 0.090 |
Why?
|
| Infant | 2 | 2019 | 12304 | 0.090 |
Why?
|
| Giardiasis | 1 | 1990 | 10 | 0.090 |
Why?
|
| Child Day Care Centers | 1 | 1990 | 25 | 0.090 |
Why?
|
| Honduras | 2 | 2001 | 22 | 0.090 |
Why?
|
| Physician-Patient Relations | 1 | 2013 | 423 | 0.090 |
Why?
|
| Cytomegalovirus | 1 | 1990 | 269 | 0.080 |
Why?
|
| Africa | 2 | 1999 | 125 | 0.080 |
Why?
|
| Typhoid Fever | 2 | 1985 | 19 | 0.080 |
Why?
|
| Aged | 7 | 2012 | 18735 | 0.070 |
Why?
|
| Bacteremia | 1 | 1992 | 405 | 0.070 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 1988 | 93 | 0.070 |
Why?
|
| Mycobacterium tuberculosis | 2 | 2010 | 460 | 0.070 |
Why?
|
| Mental Disorders | 1 | 2014 | 820 | 0.070 |
Why?
|
| Cohort Studies | 1 | 2015 | 4633 | 0.060 |
Why?
|
| Adolescent | 7 | 2012 | 18929 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 1 | 2007 | 488 | 0.060 |
Why?
|
| Child | 7 | 2012 | 24049 | 0.060 |
Why?
|
| Mefloquine | 1 | 2003 | 2 | 0.060 |
Why?
|
| Cholera | 1 | 1983 | 25 | 0.050 |
Why?
|
| Animals | 7 | 2010 | 33724 | 0.050 |
Why?
|
| Sepsis | 1 | 1988 | 472 | 0.050 |
Why?
|
| Foodborne Diseases | 1 | 1983 | 11 | 0.050 |
Why?
|
| Plasmodium falciparum | 1 | 2003 | 62 | 0.050 |
Why?
|
| Emergency Medical Services | 1 | 2007 | 430 | 0.050 |
Why?
|
| Construction Materials | 1 | 2001 | 4 | 0.050 |
Why?
|
| Retrospective Studies | 5 | 2007 | 15856 | 0.050 |
Why?
|
| AIDS-Related Opportunistic Infections | 2 | 1999 | 139 | 0.040 |
Why?
|
| Syndrome | 1 | 2003 | 1109 | 0.040 |
Why?
|
| Renal Dialysis | 1 | 2007 | 841 | 0.040 |
Why?
|
| Child, Preschool | 3 | 2012 | 13781 | 0.040 |
Why?
|
| HIV-2 | 1 | 1999 | 8 | 0.040 |
Why?
|
| Communicable Disease Control | 1 | 2001 | 140 | 0.040 |
Why?
|
| Spinal Diseases | 1 | 1999 | 46 | 0.040 |
Why?
|
| Radiography | 1 | 2001 | 804 | 0.040 |
Why?
|
| Young Adult | 1 | 2012 | 8772 | 0.040 |
Why?
|
| El Salvador | 1 | 1997 | 4 | 0.040 |
Why?
|
| Hospitals, Teaching | 1 | 1998 | 102 | 0.040 |
Why?
|
| Health Services Needs and Demand | 1 | 1999 | 171 | 0.040 |
Why?
|
| Substance Abuse, Intravenous | 1 | 1997 | 39 | 0.040 |
Why?
|
| Homosexuality, Male | 1 | 1997 | 61 | 0.040 |
Why?
|
| Hospitals, Urban | 1 | 1997 | 93 | 0.040 |
Why?
|
| CD4 Lymphocyte Count | 1 | 1997 | 230 | 0.040 |
Why?
|
| Civil Rights | 1 | 1996 | 10 | 0.040 |
Why?
|
| Transfusion Reaction | 1 | 1997 | 38 | 0.030 |
Why?
|
| Prejudice | 1 | 1996 | 35 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 1998 | 240 | 0.030 |
Why?
|
| HIV Antibodies | 1 | 1997 | 69 | 0.030 |
Why?
|
| World Health Organization | 1 | 1996 | 110 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2007 | 5965 | 0.030 |
Why?
|
| Tuberculosis, Meningeal | 1 | 1996 | 29 | 0.030 |
Why?
|
| Odds Ratio | 1 | 1999 | 1230 | 0.030 |
Why?
|
| Sexual Behavior | 1 | 1997 | 234 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 1996 | 303 | 0.030 |
Why?
|
| Meat | 2 | 1985 | 48 | 0.030 |
Why?
|
| Taenia | 1 | 1994 | 5 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 1998 | 1226 | 0.030 |
Why?
|
| Praziquantel | 1 | 1994 | 11 | 0.030 |
Why?
|
| Meat Products | 2 | 1984 | 5 | 0.030 |
Why?
|
| Risk Factors | 3 | 2005 | 9864 | 0.030 |
Why?
|
| Food Microbiology | 2 | 1984 | 25 | 0.030 |
Why?
|
| Otitis | 2 | 1983 | 11 | 0.030 |
Why?
|
| Seawater | 2 | 1983 | 13 | 0.030 |
Why?
|
| Ostreidae | 2 | 1983 | 27 | 0.030 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2014 | 80 | 0.030 |
Why?
|
| Poultry Products | 1 | 1992 | 2 | 0.030 |
Why?
|
| Turkeys | 1 | 1992 | 6 | 0.030 |
Why?
|
| Los Angeles | 1 | 1992 | 18 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2001 | 3301 | 0.020 |
Why?
|
| Disease Progression | 1 | 1998 | 1992 | 0.020 |
Why?
|
| Diarrhea | 2 | 1983 | 318 | 0.020 |
Why?
|
| Prevalence | 1 | 1997 | 2366 | 0.020 |
Why?
|
| USSR | 1 | 1990 | 5 | 0.020 |
Why?
|
| Gastroenteritis | 2 | 1983 | 332 | 0.020 |
Why?
|
| Homosexuality | 1 | 1990 | 18 | 0.020 |
Why?
|
| Zidovudine | 1 | 1990 | 22 | 0.020 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 1990 | 37 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2014 | 1081 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1999 | 3448 | 0.020 |
Why?
|
| Cytomegalovirus Infections | 1 | 1990 | 218 | 0.020 |
Why?
|
| Pregnancy | 1 | 1999 | 7092 | 0.020 |
Why?
|
| Neutropenia | 1 | 1988 | 202 | 0.020 |
Why?
|
| Animal Husbandry | 1 | 2005 | 10 | 0.020 |
Why?
|
| Prognosis | 2 | 1992 | 4484 | 0.020 |
Why?
|
| Mexico | 1 | 2005 | 178 | 0.020 |
Why?
|
| Food Contamination | 1 | 1985 | 23 | 0.020 |
Why?
|
| Respirovirus Infections | 1 | 1984 | 19 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 1992 | 3228 | 0.010 |
Why?
|
| Botulinum Antitoxin | 1 | 1984 | 3 | 0.010 |
Why?
|
| Mexican Americans | 1 | 2005 | 169 | 0.010 |
Why?
|
| Botulism | 1 | 1984 | 9 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 1985 | 160 | 0.010 |
Why?
|
| Clostridium perfringens | 1 | 1983 | 7 | 0.010 |
Why?
|
| Diagnosis, Differential | 2 | 1999 | 1872 | 0.010 |
Why?
|
| Swine | 1 | 2005 | 1157 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2014 | 12020 | 0.010 |
Why?
|
| Pneumonia, Viral | 1 | 1984 | 378 | 0.010 |
Why?
|
| Central Nervous System Diseases | 1 | 1999 | 105 | 0.010 |
Why?
|
| Hospitals, Municipal | 1 | 1996 | 2 | 0.010 |
Why?
|
| Africa South of the Sahara | 1 | 1997 | 112 | 0.010 |
Why?
|
| Time Factors | 2 | 1984 | 6168 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1996 | 995 | 0.010 |
Why?
|
| Survival Analysis | 1 | 1996 | 1467 | 0.010 |
Why?
|
| Mass Screening | 1 | 1997 | 780 | 0.010 |
Why?
|
| Incidence | 1 | 1996 | 3004 | 0.000 |
Why?
|
| Homes for the Aged | 1 | 1984 | 24 | 0.000 |
Why?
|
| California | 1 | 1984 | 127 | 0.000 |
Why?
|
| Salmonella typhi | 1 | 1984 | 15 | 0.000 |
Why?
|
| Nursing Homes | 1 | 1984 | 95 | 0.000 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 1984 | 145 | 0.000 |
Why?
|
| Cattle | 1 | 1984 | 555 | 0.000 |
Why?
|
| Feces | 1 | 1984 | 705 | 0.000 |
Why?
|
| Antibodies, Viral | 1 | 1984 | 1131 | 0.000 |
Why?
|
| Age Factors | 1 | 1984 | 2774 | 0.000 |
Why?
|